Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries (StratMed-MINOCA)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 379 participants.

Also called NCT05198791

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 379 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05198791
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05198791. Randomized; double masking; primary purpose treatment. Start 2022-02-04 (actual); primary completion 2026-11-18 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries (StratMed-MINOCA)
Acronym
StratMedMINOCA
Condition
Myocardial Infarction, Acute
Condition
Myocardial Infarction With Nonobstructive Coronary Arteries
Condition
Myocardial Injury
Intervention (Drug)
Stratified medicine - Microvascular dysfunction and eplerenone therapy, tablets
Intervention (Other)
Stratification and standard care
Lead sponsor
NHS National Waiting Times Centre Board (class: other)
Collaborator
British Heart Foundation (class: other)
Collaborator
Abbott (class: industry)

Record details

Record id
cardio:ct-nct05198791
Content hash
2f0da36768b2361ec96f14f0291652a21549507035ac087861d9818bb3df3bdf